CLDN6-positive Solid Tumor
1 clinical trials · Condition
◉ Watch CLDN6-positive Solid Tumor
| Record | Firm | Date |
|---|---|---|
| A Study of ASP1893 in Adults With Advanced CLDN6-positive Solid Tumors (NCT06681870) | Astellas Pharma Global Development, Inc. | 2024-12-31 |
Track CLDN6-positive Solid Tumor automatically
Every clearance here is in the API, with alerts when new ones post.